Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changshu Huabao Medicine is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and high-end pharmaceutical intermediates. The company focuses primarily on cardiovascular and metabolic therapeutic areas, producing key components for widely used drugs such as statins and antiplatelet agents. Operating out of Jiangsu Province, the firm maintains modern production facilities that adhere to international quality standards, including GMP certifications. Their business model centers on supplying high-quality chemical precursors and finished APIs to global pharmaceutical formulators and distributors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changshu Huabao Medicine.